AAQ.DE - aap Implantate AG

XETRA - XETRA Delayed Price. Currency in EUR

aap Implantate AG

Lorenzweg 5
Berlin 12099
Germany
49 30 75019 0
http://www.aap.de

SectorHealthcare
IndustryMedical Devices
Full Time Employees141

Key Executives

NameTitlePayExercisedYear Born
Mr. Bruke Seyoum Alemu Dipl.-Ing.Chairman of Management Board & CEO335kN/A1966
Mr. Marek HahnMember of Management Board & CFO237kN/A1974
Nanette HüdepohlHead of Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany and the United States. The company offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. It also provides bone graft substitutes, including Artosal, a fully synthetic osteoconductive bone substitute; Cerabone, a ceramic bone replacement material; PerOssal, a synthetic biodegradable osteostimulating and osteoconductive bone replacement material; Calcifix, a calcium phosphate cement; and ReproBone, an injectable granulated paste, as well as GlassBONE, a bioactive glass. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Corporate Governance

aap Implantate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.